Antipsychotic Treatment of 22q11.2 Deletion Syndrome-Related Psychoses.

Pharmacopsychiatry
Elias AngelopoulosEleftheria Tsaltas

Abstract

In the recent study by Verhoeven and Egger, 2015 and the recent letter to the editor by Boot et al. 2015 an emphasis is given to the best possible pharmacological treatment of 22q11-2 Deletion-Syndrome related psychoses. We would like to present the case of a 23-year old Cypriot patient with 22q11.2 deletion syndrome who fulfilled criteria for treatment resistant schizophrenia (TRS). He was sequentially treated with aripiprazole, risperidone, olanzapine, haloperidol and a combination treatment with olanzapine and haloperidol. Clozapine was the only antipsychotic medication that has improved his condition.

Citations

Aug 14, 2019·American Journal of Medical Genetics. Part a·Janna de BoerJanneke Zinkstok
Nov 7, 2018·The Mental Health Clinician·Ann Marie RuheDavid Procaccini
Nov 25, 2017·International Journal of Developmental Disabilities·Maria Hagen EngebretsenTrine Lise Bakken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.